Article
Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.
Leukemia & lymphoma - 1 Jun 2012
Erčulj Nina, Kotnik Barbara Faganel, Debeljak Maruša, Jazbec Janez, Dolžan Vita
Abstract excerpt
The prediction of high-dose methotrexate (HD-MTX) toxicity is a key issue in the individualization of treatment in childhood acute lymphoblastic leukemia (ALL). Our aim was to evaluate the influence of MTX pathway polymorphisms on HD-MTX treatment outcome in children with ALL. In total, 167 children with ALL were genotyped for methylenetetrahydrofolate dehydrogenase (MTHFD1) 1958G > A, methylenetetrahydrofolate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
